What is it about?
Retinal Ischemia is a treatable condition, particularly in the 50% of the population the MTHFR C677T folate polymorphisms.
Featured Image
Why is it important?
Prior to Ocufolin, no treatment of BRAO after 4 hours has shown benefit.
Perspectives
This case demonstrated that 24 hours out is not too late to start treating severe retinal ischemia. The patient over 9 months improved from 20/70 to 20/25. Other patients with BRAO since then have shown remarkable improvement. A subsequent series demonstrating the impact of l-methylfolate, and n-acetylcysteine containing supplements is under preparation.
Dr Craig J Brown
University of Arkansas for Medical Sciences
Read the Original
This page is a summary of: Preservation of retinal structure and function after cilioretinal artery occlusion: a case report, International Medical Case Reports Journal, February 2016, Dove Medical Press,
DOI: 10.2147/imcrj.s96858.
You can read the full text:
Contributors
The following have contributed to this page
